You are here: Industry Insights > RSV

News List

Nirsevimab gets Promising Innovative Medicine Designation from MHRA expresspharma
January 19, 2021
Nirsevimab is an innovative monoclonal antibody in Phase 2 and Phase 3 trials for the prevention of respiratory syncytial virus (RSV) infections in healthy late preterm, term and high-risk infants.
Cepheid Receives CE-IVD Registration for SARS-CoV-2, Flu A, Flu B, RSV Combination Test americanpharmaceuticalreview
December 10, 2020
Cepheid announced the CE-IVD marking of Xpert® Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample.
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe prnasia
December 03, 2020
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. said Thursday that the extraction-free application of Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is now available in Europe.
GENETWORx Labs Launches New All-In-One Test that Detects COVID-19/Flu/RSV prnewswire
December 02, 2020
TCA/GENETWORx Labs unveiled a new breakthrough diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample.
Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches prnewswire
November 19, 2020
Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV).
Pathnostics Launches Single Test to Detect COVID-19, Flu and RSV prnewswire
October 29, 2020
Pathnostics announced that it has launched a multiplex polymerise chain reaction (PCR) test that simultaneously detects multiple respiratory infections, including COVID-19, influenzas A/B and respiratory syncytial virus (RSV).
Final Report Confirms Remdesivir Benefits for COVID-19 americanpharmaceuticalreview
October 28, 2020
Remdesivir is an antiviral medication that targets a range of viruses. It was originally developed over a decade ago to treat hepatitis C and a cold-like virus called respiratory syncytial virus (RSV). Remdesivir wasn’t an effective treatment for ...
Moderna regains RSV vaccine programme from Merck pharmaceutical-technology
October 12, 2020
Merck (MSD) has returned all rights to a respiratory syncytial virus (RSV) vaccine, mRNA-1172, to Moderna, including rights to develop vaccines against the virus for adults.
Cepheid Receives EUA for SARS-CoV-2, Flu A, Flu B and RSV Combination Test americanpharmaceuticalreview
October 09, 2020
Cepheid has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19 ...
ReViral secures FDA fast track status for sisunatovir to treat severe RSV infection pharmaceutical-business-review
August 06, 2020
Clinical-stage biopharmaceutical company ReViral has secured fast track designation from the US Food and Drug Administration (FDA) for its sisunatovir to treat patients with serious respiratory syncytial virus (RSV) infection.

Previous page 1 2 3 4 Next page